Steward Partners Investment Advisory, LLC Kazia Therapeutics LTD Transaction History

Steward Partners Investment Advisory, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.73 - $1.16 $36 - $57	-50 Reduced 66.67%	25 $0
Q3 2022 Nov 10, 2022	SELL	$1.1 - $4.19 $27 - $104	-25 Reduced 25.0%	75 $0
Q3 2020 Oct 30, 2020	SELL	$3.33 - $8.26 $749 - $1,858	-225 Reduced 69.23%	100 $1,000
Q1 2020 Apr 29, 2020	SELL	$2.72 - $4.64 $680 - $1,160	-250 Reduced 43.48%	325 $0
Q2 2019 Jul 25, 2019	BUY	$2.31 - $3.58 $1,328 - $2,058	575 New	575 $1,000
Q4 2018 Jan 15, 2019	SELL	$2.2 - $3.18 $1,210 - $1,749	-550 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$3.05 - $3.9 $1,677 - $2,145	550 New	550 $2,000

2.13M

93.2K

Ticker KZIA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,111,300
Market Cap $87.5M
Description
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.